Data / Form D filings / Chimeros Inc
Chimeros Inc: Form D filings
Chimeros Inc, a biotechnology company in San Diego, CA, filed 8 Form D notices with the SEC between 2009 and 2011. The latest, on August 10, 2011, reports $760,945 sold of a $760,945 offering to 1 investor.
Find out what Chimeros Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3030 BUNKER HILL STREET, SUITE 102, San Diego, CA, 92109
- Phone
- (858) 622-0796
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1340917
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2011 | New notice | $760,945 | $760,945 | $0 | 1 | Jul 29, 2011 | sec.gov |
| Aug 10, 2011 | New notice | $375,000 | $375,000 | $0 | 2 | Aug 1, 2011 | sec.gov |
| Apr 13, 2011 | New notice | $600,000 | $600,000 | $0 | 5 | Apr 8, 2011 | sec.gov |
| Dec 3, 2010 | New notice | $750,000 | $750,000 | $0 | 11 | Dec 2, 2010 | sec.gov |
| Oct 28, 2010 | Amendment | $500,000 | $433,537 | $66,463 | 15 | Jun 30, 2010 | sec.gov |
| Jul 20, 2010 | New notice | $500,000 | $144,512 | $355,488 | 15 | Jun 30, 2010 | sec.gov |
| Apr 8, 2010 | New notice | $500,000 | $444,081 | $55,919 | 16 | Mar 15, 2010 | sec.gov |
| Oct 9, 2009 | New notice | $611,246 | $611,246 | $0 | 1 | Sep 9, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alex D. Barkas, Ph.D. | Director | |
| Ilan D. Zipkin, Ph.D. | Executive Officer, Director | |
| Miguel D. de los Rios, Ph.D. | Executive Officer, Director | |
| David J. Lockhart, Ph.D. | Director | |
| Frank D. Foster | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Aug 8, 2011 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Chimeros Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.